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. Background
Gallbladder cancer (GBC) has a poor prognosis [1]. One rea-
on for this is the difﬁculty in determining the extent of cancer
rogression. Therefore, determining the extent of cancer spread
s important. Recent advances in diagnostic imaging have led to
mprovement in the preoperative diagnosis rate of GBC. However,
t is still difﬁcult to diagnose minute foci of metastasis and assess
he extent of cancer spread to regional lymph nodes, extrahepatic
ile duct, and so on.
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/).In our hospital, staging laparoscopy is performed intraopera-
tively to improve the diagnostic rates of these lesions. In addition,
intraoperative consultation is used for a more reliable diagno-
sis. However, there are cases in which identiﬁcation of cancer
is difﬁcult with staging laparoscopy and even submission of a
tissue specimen for intraoperative consultation may  not be pos-
sible. Furthermore, intraoperative consultation is possible only in
large hospitals where a pathologist is available on site. Thus, sev-
eral issues need to be addressed. To resolve these problems, we
attempted to use 5-aminolevulinic acid (5-ALA) as a diagnostic tool
for GBC.
5-ALA is an amino acid and a heme precursor present in the
living body. It has been used for photodynamic diagnosis (PDD)
and photodynamic therapy (PDT), because one of its metabolites—
protoporphyrin IX (PpIX)- emits blue-excited red ﬂuorescence and
accumulates speciﬁcally in cancer cells. 5-ALA is routinely used in
the ﬁelds of neurosurgery, urology and dermatology: however, few
studies have reported on its use in the ﬁeld of gastroenterology [2]
[3].
We previously reported that 5-ALA is useful in the diagnosis of
lymph node metastases of colorectal, gastric, and pancreatic can-
cer [4] [5]. A recent report found that 5-ALA is taken up by some
GBC cell lines, thus indicating that 5-ALA can also be useful in the
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pig. 1. The preoperative CT scan and PET. A: CT scan showed a contrast-enhanced m
ymph  node. B: PET showed radioactivity accumulation in the gallbladder fundus. D
linical management of GBC. We  recently encountered a case of
BC where the use of 5-ALA-mediated PDD in surgery allowed for
ntraoperative diagnosis of lymph node metastasis.
. Case presentation
Our patient was a 76-year-old man  with GBC. Ultrasonography,
onducted during a health checkup, revealed a gallbladder tumor. A
ubsequent detailed examination conﬁrmed the diagnosis of GBC,
nd the patient was referred to our department for surgery.
His height and weight was 160 cm,  and 55 kg, respectively, and
is body mass index was 21.5. Abdominal ﬁndings were unremark-
ble and all tumor markers were negative.
Preoperative computerized tomography (CT) scan revealed a
ontrast-enhanced mass in the gallbladder fundus (Fig. 1A). In addi-
ion, swelling was noted in the regional lymph nodes and para aortic
ymph node (Fig. 1C). positron emission tomography (PET) showed
adioactivity accumulation in the gallbladder fundus (Fig. 1B) and
he regional lymph nodes but not in the para aortic lymph node
Fig. 1D).
On the basis of these ﬁndings, GBC (cT2N2M0, cStage IIIB
UICC7th [6])) was diagnosed and the patient was scheduled for
urgery. The surgical plan was to ﬁrst perform staging laparoscopy,
o check for peritoneal dissemination. Next, resection of para aor-
ic lymph node and subsequent submission of the lymph node
pecimen for intraoperative consultation were planned. If the
athological examination was negative, gallbladder bed resection
nd regional lymph node dissection were to be performed. And if
t was positive, cholecystectomy was to be performed.
The patient administered with 5-ALA 4 h before surgery. Oper-
tion was performed under general anesthesia. During staging
aparoscopy, 5-ALA-mediated PDD was performed. Macroscopic
eritoneal dissemination was absent on staging laparoscopy and on
-ALA-mediated PDD. Following these ﬁndings, the tissue around
ara aortic lymph node was freed to collect a specimen forf 17 mm in the gallbladder fundus. C: CT scan revealed a swelling of the para aortic
did not show radioactivity accumulation in the para aortic lymph node.
intraoperative consultation. When the para aortic lymph node was
exposed, ﬂuorescence was  examined and red ﬂuorescence was
noted, strongly suggesting metastasis (Fig. 2A, B). Intraoperative
consultation revealed adenocarcinoma in part of the lymph node,
supporting the ﬂuorescence-based diagnosis of GBC metastasis to
the lymph node (Fig. 2C). The excised gallbladder also emitted
ﬂuorescence. Pathological diagnosis of the gallbladder was adeno-
carcinoma, and showed that it matched the ﬂuorescence site.
3. Conclusions
GBC has a poor prognosis and most GBCs are discovered at a
late stage. According to the Japanese Association of Clinical Can-
cer Centers, the 5-year (2001–2005) survival rate for GBC among
its member hospitals is 19.9% [1]. Therefore, accurate preoperative
diagnosis of the extent of GBC spread and exploration of its lymph
node metastasis are important. In the present case, the use of 5-ALA,
a ﬂuorescent precursor enabled intraoperative diagnosis of lymph
node metastasis.
5-ALA is an endogenous amino acid serving as a heme precursor
and it is converted into PpIX in the mitochondria. PpIX accumulates
speciﬁcally in cancer cells because of the activity of enzymes and
the expression of transporters of 5-ALA pathway. PpIX emits ﬂuo-
rescence (primarily at 635 nm)  when excited by 405 nm blue light.
Thus, irradiation of excitation light in patients administered with
5-ALA enables the detection of cancer-speciﬁc ﬂuorescence [2–5].
Many studies have reported on the use of 5-ALA-mediated PDD
[2–5]. We  previously reported that 5-ALA is useful in detecting
metastasis of gastrointestinal cancer. To date, however, no report
on the clinical application of PDD in the management of GBC has
been published. Therefore, the ﬁndings of the present case are quite
valuable. According to our previous report, the accurate diagnosis
rate by using 5-ALA-mediated PDD was 92.0% for colorectal cancer
metastasis to lymph nodes and 92.4% for gastric cancer metastasis
to lymph nodes [4] [5].
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Detection of metastatic lymph nodes using 5-aminolevulinic acid in patients
with gastric cancer, Ann. Surg. Oncol. 20 (11) (2013) 3541–3548, http://dx.doi.
org/10.1245/s10434-013-3017-3.ig. 2. The para aortic lymph node. A: white lite. B: 405 nm excitation. Exposure tim
ntraoperative consultation revealed adenocarcinoma in part of the lymph node.
The lymph node involvement that was intraoperatively diag-
osed using 5-ALA-mediated PDD in the present case was  also
onﬁrmed by intraoperative consultation. 5-ALA-mediated PDD in
 patient with GBC allowed intraoperative diagnosis of lymph node
etastasis. Because 5-ALA-mediated PDD can additionally detect
eritoneal dissemination and distant metastasis, this technique
ppears to be useful for screening during staging laparoscopy. 5-
LA-mediated PDD allowed for necessary and sufﬁcient resection
o be performed with minimal invasion. However, this is a case
eport and further studies with additional cases are necessary for
eﬁnitive conclusions.eferences
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